Skip to content
Posted on
March 29, 2024
by:
fin
布里吉生物技術與愛默里大學醫學院合作探索BBT-877與抗PD-1阻斷劑聯合治療對KRAS/P53突變的NSCLC患者的組合療法
Hong Kong PR
Posted on
March 29, 2024
by:
fin
布里吉生物技術與愛默里大學醫學院合作探索BBT-877與抗PD-1阻斷劑聯合治療對KRAS/P53突變的NSCLC患者的組合療法
Menu
Home
SeaPRwire
ACN Newswire
JCN Newswire
EQS Newswire
Contact
Oops! That page can't be found.
It looks like nothing was found at this location. Maybe try a search?
Search for:
Search